Martin H, Martin C
Ann Otolaryngol Chir Cervicofac. 1984;101(7):561-3.
Our experience of the control of epistaxis by "in situ" injections of tissucol is essentially based on the use of this procedure for the treatment of epistaxis associated with Rendu-Osler's disease. We reported our first trials of this technique at the meeting organised by Immuno France Laboratories in Bordeaux in November 1983. Since this time, our initial experience has been greatly enriched, with very good results. We have treated two unusual cases of very severe epistaxis which did not respond to any of the treatments administered. We feel that these special cases warrant being reported in order to demonstrate the value of this technique.
我们通过“原位”注射凝血酶原复合物控制鼻出血的经验主要基于将该方法用于治疗与遗传性出血性毛细血管扩张症相关的鼻出血。1983年11月,我们在法国免疫实验室于波尔多组织的会议上报告了这项技术的首次试验情况。从那时起,我们的初步经验得到了极大丰富,效果非常好。我们治疗了两例异常严重的鼻出血病例,这些病例对所采用的任何治疗方法均无反应。我们认为这些特殊病例值得报告,以证明这项技术的价值。